Weight gain combined with late first pregnancy or nulliparity is associated with an increased risk for breast cancer.

Simultaneous liver transplant and sleeve gastrectomy yield durable weight loss, resolution of diabetes and hypertension, and a reduction in allograft steatosis development.

Individuals with type 1 (T1D) and type 2 diabetes have a higher risk for ischemic stroke, but those with T1D also have a higher risk for hemorrhagic stroke.

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

Adolescent hyperglycemia and worsening insulin resistance are associated with an increased risk for worsening structural and functional cardiac damage.

Expert testimony was key to an endocrinologist's fate after a patient died from metastatic lung cancer & he was sued for ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

Thyroid cancer-associated syndromes, including multiple endocrine neoplasia type 2, were significantly more prevalent than current estimates.

The following 3 color food additives have been approved by the FDA: Galdieria extract blue, butterfly pea flower extract, and calcium phosphate. HealthDay News — The U.S. Food and Drug Administration ...

GLP-1 RA treatment was linked to 8 fewer AHI events per hour among individuals with elevated body weight and moderate to severe OSA who did not have diabetes. Glucagon-like peptide-1 receptor agonists ...

Topline data were announced from a phase 3 trial evaluating somapacitan in children born small for gestational age, with Noonan syndrome, or with idiopathic short stature.